Clinically Studied Collagen Peptides Supplement Private Label

Private label and OEM manufacturing partnerships enable brands to enter the supplement market with differentiated, scientifically validated products without the capital intensity of in-house production facilities. Collagen peptides represent the largest and fastest-growing segment of the beauty-from-within supplement market, now exceeding $8 billion globally. The key scientific distinction is between collagen types: Type I (dominant in skin, tendons, bone) accounts for 90% of skin collagen and is the primary target for beauty supplements; Type II (cartilage, joints) is the focus for joint health products; Type III (skin, blood vessels) is often co-administered with Type I. Bioactive collagen peptides (hydrolyzed collagen) are produced by enzymatic hydrolysis to produce small peptides (1,000–5,000 Da average molecular weight) that retain bioactive sequences including glycine-proline-hydroxyproline (Gly-Pro-Hyp) and glycine-hydroxyproline — tripeptides shown in pharmacokinetic studies to be bioavailable and detectable in blood 1–2 hours after ingestion. A 2019 double-blind RCT demonstrated that 2.5 g/day of specific collagen peptides reduced wrinkle depth by 20% and increased skin elasticity by 31% over 8 weeks versus placebo.